Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The Latest Innovations in the Drug Pipeline for Multiple Sclerosis.
[Clinical features of neuromyelitis optica and the distribution of Chinese medical syndrome types: a case report of 63 cases].
Sodium channels in astroglia and microglia.
The TRUST (EvaluaTion of Bladder Function in Relapsing-Remitting MUltiple Sclerosis Patients Treated with Natalizumab) Observational Study.
Therapeutic strategies of urinary disorders in MS. Practice and algorithms.
Myasthenia gravis complicated with optic neuritis showing anti-aquaporin 4 antibody: a case report.
Clinical Improvement after Extracranial Venoplasty in Multiple Sclerosis.
Pilot study of minocycline in relapsing-remitting multiple sclerosis.
Myelin reactive T cells after T cell vaccination in multiple sclerosis: cytokine profile and depletion by additional immunizations.
Protective effects of N-acetyl-L-cysteine in human oligodendrocyte progenitor cells and restoration of motor function in neonatal rats with hypoxic-ischemic encephalopathy.
Predictors of disability worsening in clinically isolated syndrome.
Optical Coherence Tomography versus Visual Evoked Potentials in detecting subclinical visual impairment in multiple sclerosis.
Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
Immunomodulatory effects of helminths and protozoa in multiple sclerosis and experimental autoimmune encephalomyelitis.
Suicidal Behavior and Neurological Illnesses.
Cost-effectiveness analysis of interferon Beta-1b for the treatment of patients with a first clinical event suggestive of multiple sclerosis.
Health beliefs and physical activity behavior in adults with multiple sclerosis.
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica.
Spasticity in patients with multiple sclerosis - clinical characteristics, treatment and quality of life.
Therapeutic potential of a novel cannabinoid agent CB52 in the mouse model of experimental autoimmune encephalomyelitis.
Connexin astrocytopathy and novel therapeutic strategy targeting connexin hemichannels in demyelinating disease.
Increased Th17 response to myelin peptides in pediatric MS.
Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunity.
[Compensatory mechanisms in multiple sclerosis(review)].
The Lateral Membrane Organization and Dynamics of Myelin Proteins PLP and MBP Are Dictated by Distinct Galactolipids and the Extracellular Matrix.

Pages